OCUP Ocuphire: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

OCUP (Ocuphire Corporation) - tandha merek perusahaan

Risks for Ocuphire Pharma, Inc. (OCUP) are linked to the anticipation of late-stage drug trial results for retinopathy, which supports the current EPS growth forecast for the next period. The value of -2.60 reflects the current volume of this metric. Stability is provided by Nyxol's authority in ophthalmology, while eco-friendly drug synthesis and zero-waste laboratories minimize operational threats, supporting sustainable business development.

OCUP: Prakiraan wutah bathi saben saham kanggo taun ngarep Ocuphire Corporation 04.07.2022 - 24.10.2024

Ocuphire Pharma (OCUP) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:ocuphire.com, OCUP
Barang utama ocuphire.com

The stability of Ocuphire Pharma, Inc. (OCUP) depends on the commercialization of drugs for presbyopia therapy and retinal protection, which directly impacts future cash flows. This indicator assesses the expected profit dynamics for the coming year, adjusting historical data for inflationary risks and personnel costs, which allows for a forecast of the asset's real investment attractiveness through the modeled EPS growth for the next fiscal year.

Analisis pesaing

ALC (Alcon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Bausch + Lomb Corporation (BLCO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GKOS|Prakiraan wutah bathi kanggo taun ngarep Apellis Pharmaceuticals, Inc. (APLS)|Prakiraan wutah bathi kanggo taun ngarep BLTE (Belite Bio)|OCUL - Prakiraan wutah bathi saben saham kanggo taun ngarep|HROW - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Oculis Holding AG - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep eyepointpharma.com|Prakiraan wutah bathi kanggo taun ngarep Kodiak Sciences Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aldeyra Therapeutics Inc. (ALDX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep KALA (KALA BIO)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep opusgtx.com IRD|Dinamika bathi saben saham sing diarepake ing taun ngarep OKYO|ADVM: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep OTLK (Outlook Therapeutics)|CLSD: Prakiraan wutah bathi kanggo taun ngarep|NovaBay Pharmaceuticals Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kiorapharma.com|Prakiraan wutah bathi saben saham kanggo taun ngarep Alimera Sciences (ALIM)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Eyenovia Corp (EYEN)|GHSI - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OPT (Opthea Ltd)